LGMay 23, 2022Code
PyRelationAL: a python library for active learning research and developmentPaul Scherer, Alison Pouplin, Alice Del Vecchio et al.
Active learning (AL) is a sub-field of ML focused on the development of methods to iteratively and economically acquire data by strategically querying new data points that are the most useful for a particular task. Here, we introduce PyRelationAL, an open source library for AL research. We describe a modular toolkit based around a two step design methodology for composing pool-based active learning strategies applicable to both single-acquisition and batch-acquisition strategies. This framework allows for the mathematical and practical specification of a broad number of existing and novel strategies under a consistent programming model and abstraction. Furthermore, we incorporate datasets and active learning tasks applicable to them to simplify comparative evaluation and benchmarking, along with an initial group of benchmarks across datasets included in this library. The toolkit is compatible with existing ML frameworks. PyRelationAL is maintained using modern software engineering practices -- with an inclusive contributor code of conduct -- to promote long term library quality and utilisation. PyRelationAL is available under a permissive Apache licence on PyPi and at https://github.com/RelationRx/pyrelational.
QMFeb 7, 2022
RECOVER: sequential model optimization platform for combination drug repurposing identifies novel synergistic compounds in vitroPaul Bertin, Jarrid Rector-Brooks, Deepak Sharma et al.
For large libraries of small molecules, exhaustive combinatorial chemical screens become infeasible to perform when considering a range of disease models, assay conditions, and dose ranges. Deep learning models have achieved state of the art results in silico for the prediction of synergy scores. However, databases of drug combinations are biased towards synergistic agents and these results do not necessarily generalise out of distribution. We employ a sequential model optimization search utilising a deep learning model to quickly discover synergistic drug combinations active against a cancer cell line, requiring substantially less screening than an exhaustive evaluation. Our small scale wet lab experiments only account for evaluation of ~5% of the total search space. After only 3 rounds of ML-guided in vitro experimentation (including a calibration round), we find that the set of drug pairs queried is enriched for highly synergistic combinations; two additional rounds of ML-guided experiments were performed to ensure reproducibility of trends. Remarkably, we rediscover drug combinations later confirmed to be under study within clinical trials. Moreover, we find that drug embeddings generated using only structural information begin to reflect mechanisms of action. Prior in silico benchmarking suggests we can enrich search queries by a factor of ~5-10x for highly synergistic drug combinations by using sequential rounds of evaluation when compared to random selection, or by a factor of >3x when using a pretrained model selecting all drug combinations at a single time point.